Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
FDA-related reports and medical reviews describe BPC-157 as an unapproved peptide with limited human evidence, so human safety remains uncertain
2017b;7:11420
If we have more patients than need that, it's like a Netflix subscription with unlimited subscribers, then we will have whatever it is, because then the manufacturer doesn't lose money, so they can't complain about R&D and not being able to make money
A 2015 randomized controlled trial found that 10 grams of Fibersol-2 (the fiber in HUM's product) increased postprandial GLP-1 compared to placebo (Ye et al., Nutrition Research , PubMed)
The LEAD-6 trial demonstrated liraglutides superior glycemic control and tolerability compared to exenatide [37]
Shahbaz M, Naeem H, Batool M, Imran M, Hussain M, Mujtaba A, Alsagaby SA, Al Abdulmonem W, El-Ghorab AH, Ghoneim MM, Shaker ME, Abdelgawad MA, Al Jbawi E (2024) Antioxidant, anticancer, and anti-inflammatory potential of Moringa seed and Moringa seed oil: a comprehensive approach
